Coeliac Study (DQB103CT)
Don’t let Coeliac disease control your life.
This study aims to evaluate the safety and effectiveness of an investigational medication in the treatment of Coeliac disease, an autoimmune condition that can cause gut issues, chronic fatigue, and other adverse reactions when gluten is ingested.
Eligibility
- 18 - 70 years
- Medically diagnosed with Coeliac disease
- Have been managing Coeliac disease symptoms with a gluten-free diet for at least 12 months
Location
VIC, NSW, QLD, and New Zealand
Dementia-related Agitation Study
Take part in a new research study for a potential new treatment for agitation associated with dementia.
This study aims to evaluate the effectiveness and safety of a potential new treatment for dementia-related agitation.
Eligibility
- Aged 50 - 90
- Current diagnosis of dementia
- Experiencing agitation/aggression episodes at least twice per week
- Have a caregiver or study partner who will be available to participate in the study
Location
VIC, NSW, and SA
Insomnia Study
Tired of sleepless nights?
This medical study aims to evaluate the efficacy and safety of CBD TPM (Cannabidiol, Tocopheryl Phosphate Mixture) capsules in adults to reduce the severity of insomnia symptoms.
Eligibility
- 18+
- Have difficulty getting to sleep, staying asleep and/or waking up earlier in the morning than desired
- OR have been diagnosed with insomnia.
Location
VIC, NSW, QLD, and WA
Asthma Study
We're currently recruiting for a research study comparing two approved asthma treatments to see which one works better at reducing symptoms and improving lung function.
Your participation in this study could drive innovative approaches in asthma care - enhancing not only your well-being but also extending a positive impact to others facing similar challenges.
Eligibility
- Aged 18 to 75 inclusive
- A diagnosis of asthma
- Currently experiencing asthma symptoms
Location
WA
COPD Study (Chronic Obstructive Pulmonary Disease)
Living with COPD? Consider joining a new research study investigating a potential treatment option.
TrialsWest is looking for volunteers to participate in clinical trial testing how well two different treatments may help prevent COPD flare-ups and serious heart events, like heart failure and heart attacks, in people with COPD.
Eligibility
- 40 -80 years old
- Are a current or former smoker living with COPD
- Have a history of cardiovascular disease or have risk factors for cardiovascular disease (this includes high blood pressure and high cholesterol)
Location
WA
Expression of Interest
Vitiligo Studies
We're accepting expressions of interest from adults over 18 years of age who are diagnosed with vitiligo for upcoming studies.
Eligibility
- Aged 18 and over
Location
Australia and New Zealand
.png?width=80&height=80&name=SCLC%20ICON%20(2).png)
Expression of Interest:
Atherosclerosis Studies
Register your interest in new upcoming studies for Atherosclerosis
Eligibility
- Aged 45 to 80
Location
Australia
Expression of Interest
Healthy Volunteers
Sign up to be contacted once new studies open. Healthy volunteer trials can range from virtual trials to in-house overnight stays. Every study is different, we'll always share information at the beginning of the process and you can decide to withdraw your interest at any time.
Eligibility
- 18 to 65 years of age
- Able to commit to study schedules
- No uncontrolled or serious diseases
Location
Australia
Expression of Interest
Mental Health Studies
If you are interested in participating in research investigating a potential new method of mental health diagnosis, register your interest to be kept informed when this study opens.
Eligibility
- 18+
- Currently have, or believe you may have a mental health condition
Location
Australia
Expression of Interest
Panic Disorder
This study aims to evaluate the safety and effectiveness of a potential new oral treatment for Panic Disorder in adults between 18-65 years of age.
Eligibility
- 18 to 85 years of age
- Diagnosed with Panic Disorder or struggle with recurring panic attacks
Location
NSW, SA, VIC, and QLD
Expression of Interest
Skin Cancer
Skin cancer is the uncontrolled growth of abnormal skin cells, and with 2 in 3 Australians diagnosed in their lifetime—mostly due to UV exposure—it’s one of the country’s most serious and widespread health concerns.
Eligibility
- 18 to 85 years of age
- Have Skin Cancer
Location
NSW and ACT
Need help with clinical trial information?
Search our Evrima help Centre for answers related to information about our active studies, information about managing your Evrilink account, and general clinical trial knowledge!
Read our FAQs